Document Migration
PRODUCTS
-
PHCbi brand’s 25.6 cu.ft (725L) FrostLess ultra-low temperature freezer provides reliable temperatures as low as -86°C. It is engineered to mitigate frost buildup more than our category-leading models while maintaining the reliability and energy efficiency that today's laboratories require. It operates on 115V and uses only 7.9kWh per day. ENERGY STAR® Certified.
-
Navigating the complex landscape of scientific and regulatory affairs is a challenge for biotech companies. That's why our team is committed to providing solutions tailored to meet these unique needs.
-
AES has transformed the landscape of modular cleanroom design, manufacturing and construction. What began as a vision to elevate industry standards has evolved into a legacy of cleanroom solutions that protect the world’s most critical processes.
-
Accelerate your biomanufacturing capacity with purpose-built modules
KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.
-
Chemocatalyzed steps in synthetic routes are known to afford high selectivities, yields and atom economy. A chemocatalytic reaction optimization requires large number of experiments to identify a suitable catalyst, catalyst loading, solvent, temperature, pressure etc. The chemocatalysis team at Aragen Life Sciences has the capabilities to optimize processes using high throughput screening combined with DoE from gram to multikilo scale with ready access to catalysts and ligands.
WHITE PAPERS AND CASE STUDIES
-
How To Get Products To Patients Faster With A Connected QMS
BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Discover how digital solutions streamlined their operations and improved regulatory efficiency.
-
Revolution In The EU Pharmaceutical Legislation Ahead
Discover the impact revised pharmaceutical legislation will have on the industry by superseding regulations that have fostered the availability of safe and effective medicines for the past two decades.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Preparing For Disease X: Effective Vaccine Development In The Face Of A Future Pandemic
CDMOs are playing a critical role in the global effort to prepare for future pandemics. Learn how innovative strategies and flexible platforms are helping to ensure a swift and effective response plan.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?
-
Innovative FSP Solutions For Biopharma Growth And Transition
To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.
-
Insights And Effective Strategies For A Successful Technology Transfer
Discover key strategies for seamless pharmaceutical technology transfers that accelerate time to market, ensure product quality, and meet regulatory standards across the drug lifecycle.
-
Supplier Quality And The True Cost Of Recalls
Recalls can cost millions (or even billions) and threaten a company’s public perception. Discover how to minimize recall costs and enhance compliance with effective quality management strategies.
-
Vial Fogging: Practical Considerations For Vial Selection
Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Challenges And Solutions In Lyophilization Development For ADCs
Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing.
-
10 Clinical Research Practices That Feel Like Compliance (But Aren't)
Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.
NEWS
-
Latvian Scientists Create A Tool For More Efficient Public Procurement Evaluation1/10/2026
Much of public procurement evaluation consists of manual work by experts and specialists. This is time-consuming, since it involves comparing extensive documentation, evaluating compliance with regulatory requirements—like whether there are competition-restricting criteria—and other factors.
-
NGMN Unveils Common Language For Base Station Antennas – A Milestone Toward Simplified Mobile Network Deployment7/9/2025
The procurement, testing and deployment of base station antennas – a critical component in the delivery of mobile communications – will be simpler for operators and suppliers thanks to new guidance for the creation of a ‘common language’ to describe the technology.
-
QNX And Advantech Strengthen Collaboration To Streamline Embedded Systems Development3/20/2025
QNX, a division of BlackBerry Limited and Advantech, a leading provider of embedded platforms and services, today announced an expanded collaboration to better serve their joint-customers across the embedded systems industry.
-
Acumatica Cloud ERP Delivers Advanced AI Capabilities To Boost Collaboration For Service-Driven Organizations3/26/2026
Acumatica Cloud ERP today introduced its 2026 R1 product enhancements for professional services and field service organizations, including expanded AI capabilities, enhanced reporting tools, and new collaboration features to help mid-market businesses operate efficiently and make faster, data-driven decisions.